Concepedia

Safety and efficacy of the HIV-1 attachment inhibitor prodrug BMS-663068 in treatment-experienced individuals: 24 week results of AI438011, a phase 2b, randomised controlled trial

Jacob Lalezari, Gulam Latiff, Cynthia Brinson, Juan Echevarría, Sandra Treviño‐Pérez, Johannes R. Bogner, Melanie Thompson, Jan Fourie, Otto A Sussmann Pena, Fernando C Mendo Urbina,

The Lancet HIV · 2015 · 67 citations · 16 references

DOI

Concepts

References

16

Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents

Annals of Internal Medicine · 1998 · 5.2K citations

Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada

Hasina Samji, Angela Cescon, Robert S. Hogg et al. · PLoS ONE · 2013 · 1.4K citations · Full text

Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy

Margaret May, Mark Gompels, Valérie Delpech et al. · AIDS · 2014 · 586 citations · Full text

Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1

Gerd Fätkenheuer, Anton Pozniak, Margaret Johnson et al. · Nature Medicine · 2005 · 490 citations

, , +10

Antiviral Activity, Safety, and Pharmacokinetics/Pharmacodynamics of Tenofovir Alafenamide as 10-Day Monotherapy in HIV-1–Positive Adults

Peter Ruane, Edwin DeJesus, Daniel Berger et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2013 · 304 citations